Vertex Thrombectomy System
Jupiter Endovascular · Decision date Aug 4, 2026
What did the FDA decide?
FDA records K261523 as a 510(k) premarket notification, with a decision dated Aug 4, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 4, 2026
Regulatory record facts
- Identifier
- K261523
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Jupiter Endovascular
- Product code
- QEW
- Decision code
- SESE
- Decision date
- Aug 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Peripheral Mechanical Thrombectomy With Aspiration.
- Applicant
- Jupiter Endovascular
- Product code
- QEW
- FDA device class
- 2
FDA decision timeline
K261523 received
Application receipt date recorded by FDA.
K261523 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QEW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
INDIGO Aspiration SystemK262904 | Penumbra Inc. | 510(k) clearance | Oct 15, 2026 | FDA |
Triever Duo CatheterK253419 | Inari Medical, Inc. | 510(k) clearance | Sep 18, 2026 | FDA |
| Endovascular Engineering | 510(k) clearance | Sep 3, 2026 | FDA | |
| Inari Medical, Inc. | 510(k) clearance | Aug 21, 2026 | FDA | |
| Penumbra Inc. | 510(k) clearance | Apr 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Jupiter Endovascular
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Menlo Park, CA
Sources and methodology
- Original FDA record: K261523
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



